α-Synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease.
about
Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brainCell reprogramming and neuronal differentiation applied to neurodegenerative diseases: Focus on Parkinson's diseaseInhibition of calpain prevents manganese-induced cell injury and alpha-synuclein oligomerization in organotypic brain slice culturesGenetic deletion of the GATA1-regulated protein α-synuclein reduces oxidative stress and nitric oxide synthase levels in mature erythrocytesA requirement for Gch1 and tetrahydrobiopterin in embryonic developmentDopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins α-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators.Sepiapterin reductase gene-disrupted mice suffer from hypertension with fluctuation and bradycardia.Protein-protein interaction networks identify targets which rescue the MPP+ cellular model of Parkinson's disease.Alteration of striatal tetrahydrobiopterin in iron-induced unilateral model of Parkinson's disease2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with 11C-Hydroxyephedrine PET.The E3 ubiquitin ligase seven in absentia homolog 1 may be a potential new therapeutic target for Parkinson's disease.Mitophagy in Parkinson's Disease: Pathogenic and Therapeutic Implications.Mitochondrial respiration is sensitive to cytoarchitectural breakdown.Reply: Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.
P2860
Q24321216-2CC44B7C-0CE8-40FB-9313-40BA1EFDB64AQ28080770-D18A9E45-D46D-42F3-83A8-5B5AB548DDD6Q28389635-9EAE0275-CD90-45DC-84D6-A0B57B53C86AQ28591516-8E3FFBBA-19A5-4B3C-9CE6-5BDF95F5F975Q28594127-F2A06AC6-6236-4317-AB54-2D34C5DEDCB5Q35746518-EA157EBE-B5BE-4163-8D0A-9B0CE4B8CF4CQ37727406-CC2D4A4F-0F06-4738-ADE0-1C2CA49CD78EQ38816615-DC4FD624-710B-4C2D-B41C-225B9F53398AQ38869276-637B3FD0-6AC3-4222-874A-A272CAE45368Q39475357-62AFABE9-9064-4F90-82B3-7D721C9B2ADDQ41521020-BD92B96F-4DDB-4475-B14F-A4D84639F6AEQ42372932-DBAB7896-5E2B-412B-9B14-474713C58600Q42500471-C15A87EF-45FF-4E15-BBB2-55E8A701FC2BQ42592792-884327B6-663C-4D27-BBA1-B09AD72DA607
P2860
α-Synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
α-Synuclein and mitochondrial ...... ic model of Parkinson disease.
@en
α-Synuclein and mitochondrial ...... ic model of Parkinson disease.
@nl
type
label
α-Synuclein and mitochondrial ...... ic model of Parkinson disease.
@en
α-Synuclein and mitochondrial ...... ic model of Parkinson disease.
@nl
prefLabel
α-Synuclein and mitochondrial ...... ic model of Parkinson disease.
@en
α-Synuclein and mitochondrial ...... ic model of Parkinson disease.
@nl
P2860
P50
P921
P1476
α-Synuclein and mitochondrial ...... ic model of Parkinson disease.
@en
P2093
Ashley B Hale
Lara L Lourenço-Venda
P2860
P356
10.1016/J.FREERADBIOMED.2013.10.008
P577
2013-10-19T00:00:00Z